November 14-16, 2017
Boston, MA

4 Weeks To Go! Register Here 

LinkedIn Icon

– Optimize Neoantigen ID & Validation
– Utilizing Neoantigens for Enhanced Clinical Efficacy
– Improve the Monitoring of Tumor Response to Neoantigens

The Neoantigen Summit is the dedicated end-to-end industry focused meeting ensuring the supercharging of immunotherapies and cancer vaccines to bring truly individualized therapies to patients in need.

Hear the latest clinical updates from pioneers in this field and define your commercialization roadmap to achieve future regulatory success, scale manufacturing and ensure enhanced clinical efficacy.

In such a rapidly evolving field, this is the premier platform to benchmark against the industry and network with the crème de la crème of neoantigen therapy developers.

Join us as the industry seeks to demonstrate significant clinical proof of concept and ensure you and the key stakeholders can make the scientific, clinical and commercial decisions needed to bring these therapies market.

Find Out More | View Agenda | View Speakers

"This is a unique opportunity to bring a focused group together to discuss the success and challenges that lie ahead in this field which is exciting."

Novartis

"The best meeting I have found that focuses on neoantigens specifically."

ACT Genomics

Event In Numbers